देश: दक्षिण अफ़्रीका
भाषा: अंग्रेज़ी
स्रोत: South African Health Products Regulatory Authority (SAHPRA)
Lennon
LENAPAIN TABLETS SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form:) LENAPAIN TABLETS COMPOSITION: Each tablet contains: Doxylamine Succinate 5,00 mg Codeine Phosphate 10,00 mg Caffeine , Anhydrous 30,00 mg Paracetamol 450,00 mg PHARMACOLOGICAL CLASSIFICATION: A - 2.9 : Special analgesic combination PHARMACOLOGICAL ACTION: Lenapain tablets have analgesic, antipyretic and antihistaminic action. INDICATIONS: Relief of mild to moderate pain associated with tension. CONTRA-INDICATIONS: Sensitivity to any of the ingredients. The dosage in renal functional impairment must be reduced. Should be taken only with caution by asthmatics. Severe liver function impairment. Lenapain should not be administered to patients with acute intermittent porphyria. Asthma, respiratory depression especially in the presence of cyanosis and excessive bronchial secretion, head injuries and conditions in which intracranial pressure is raised, heart failure secondary to chronic lung disease, a history of cardiac disease, epilepsy, and all convulsive states, patients taking monoamine oxidase inhibitors or within 14 days of stopping such treatment, acute alcoholism. Lenapain should not be taken during pregnancy, nor whilst breast-feeding. WARNINGS: Dosages in excess of those recommended may cause severe liver damage. Patients suffering from liver or kidney disease should take Paracetamol under medical supervision. Consult your doctor if no relief is obtained with the recommended dosage. This medicine may lead to drowsiness and impaired concentration, which may be aggravated by simultaneous intake of alcohol or other central nervous system depressant agents. Patients should be warned against taking charge of vehicles or machinery and performing potentially hazardous tasks पूरा दस्तावेज़ पढ़ें